U.S. News

Drugmakers Are Turning Patients With Rare Diseases Into D.C. Lobbyists

‘Tricks of the Trade’

Patients with the rarest afflictions are being trained as powerful advocates on Capitol Hill for new drugs and legislation that would help the industry.

KFF Health News
KFF Health News
articles/2017/04/10/drugmakers-are-turning-patients-with-rare-diseases-into-d-c-lobbyists/170410-kaiser-health-lobbyists-diseases-tease_zpsbmq
Photo Illustration by Elizabeth Brockway/The Daily Beast
KFF Health News

KFF Health News

maryagnesc@kff.org

Got a tip? Send it to The Daily Beast here.

Trending Now
OpinionUsha Vance Accidentally Reveals Very Un-MAGA Item on Her Shelf
Nell Scovell
PoliticsJeremy Clarkson Trashes ‘Idiot’ Musk Over ‘Hilarious’ Tesla Attacks
Leigh Kimmins
PoliticsDOGE Goons Tried to Fire Emergency ICU Doctors at NIH Hospital
Josh Fiallo
National SecurityTrump Team Leaks War Plans in Jaw-Dropping Security Fiasco
Josh Fiallo
PoliticsStunned Trump Learns of Massive Security Breach: ‘They Had WHAT?’
Jasmine Venet